NCS Multistage Holdings Inc (NASDAQ:NCSM) has been given an average rating of “Hold” by the ten research firms that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $12.33.
Several analysts have recently weighed in on NCSM shares. Zacks Investment Research lowered shares of ExlService from a “hold” rating to a “sell” rating in a research note on Wednesday. Piper Jaffray Companies lowered shares of NCS Multistage from an “overweight” rating to a “neutral” rating and set a $3.80 price objective for the company. in a research note on Tuesday, June 25th. Finally, ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st.
Shares of NASDAQ NCSM opened at $3.18 on Tuesday. NCS Multistage has a 52-week low of $2.46 and a 52-week high of $17.63. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.72 and a current ratio of 5.44. The stock has a 50 day moving average price of $3.03.
NCS Multistage (NASDAQ:NCSM) last released its quarterly earnings data on Monday, May 6th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The company had revenue of $52.85 million during the quarter, compared to analyst estimates of $54.65 million. NCS Multistage had a negative net margin of 101.98% and a negative return on equity of 1.11%. On average, equities research analysts expect that NCS Multistage will post -0.24 EPS for the current year.
In related news, CFO Ryan Hummer acquired 50,000 shares of the stock in a transaction dated Tuesday, May 28th. The stock was bought at an average price of $2.61 per share, for a total transaction of $130,500.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Franklin Myers acquired 40,000 shares of the stock in a transaction dated Friday, May 24th. The stock was bought at an average price of $2.57 per share, with a total value of $102,800.00. The disclosure for this purchase can be found here. Insiders bought a total of 140,000 shares of company stock valued at $364,800 in the last quarter. 11.90% of the stock is currently owned by company insiders.
Hedge funds have recently made changes to their positions in the business. Foundry Partners LLC increased its stake in NCS Multistage by 5.6% during the 1st quarter. Foundry Partners LLC now owns 386,113 shares of the company’s stock valued at $2,000,000 after purchasing an additional 20,525 shares in the last quarter. Energy Opportunities Capital Management LLC bought a new stake in NCS Multistage during the 4th quarter valued at $76,000. Dimensional Fund Advisors LP increased its stake in NCS Multistage by 51.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 288,572 shares of the company’s stock valued at $1,469,000 after purchasing an additional 97,755 shares in the last quarter. Paloma Partners Management Co bought a new stake in NCS Multistage during the 4th quarter valued at $64,000. Finally, American Century Companies Inc. bought a new stake in NCS Multistage during the 4th quarter valued at $4,264,000. Institutional investors and hedge funds own 90.77% of the company’s stock.
About NCS Multistage
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.